At a glance
- Originator Dr. Willmar Schwabe Group
- Developer Dr. Willmar Schwabe Group; University of Marburg
- Class Lactones; Neuroprotectants; Small molecules
- Mechanism of Action Antioxidants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Neurological disorders
Most Recent Events
- 24 Jan 2003 Discontinued - Preclinical for Neurological disorders (Prevention) in Germany (unspecified route)
- 06 Jul 2001 New profile
- 06 Jul 2001 Preclinical development for Neurological disorders (Prevention) in Germany (Unknown route)